HIV/AIDS

KFF/UNAIDS Analysis Finds That While Donor Government Spending on HIV Increased in 2020, Future Funding is Uncertain with COVID-19 Challenges

A new report from KFF (Kaiser Family Foundation) and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds that donor government disbursements to combat HIV in low- and middle-income countries increased by US$377 million in 2020, reaching US$8.2 billion in 2020 compared to US$7.8 billion in 2019. Donor government funding supports HIV care and treatment,…More

Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates Say

Dr. John Carlo is concerned that patients at Prism Health North Texas who rely on the health care safety net will soon be struggling even more to stay on PrEP, a medication that prevents HIV transmission. Carlo, chief executive officer of the clinic, which runs three locations in Dallas, offers free PrEP to roughly 250 …

Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates Say Read More »

Recent and Anticipated Actions to Reverse Trump Administration Section 1557 Non-Discrimination Rules

The Biden Administration has started taking steps to reverse Trump Administration policy and regulations that significantly narrowed the implementation and administrative enforcement of Section 1557, the Affordable Care Act’s nondiscrimination provision, particularly as the regulations apply to gender identity and sexual orientation. In addition, several lawsuits challenging the regulations, which were initially issued by the…More

Strides Against HIV/AIDS Falter, Especially in the South, as Nation Battles Covid

Facing a yearlong siege from the coronavirus, the defenses in another, older war are faltering. This story also ran on NPR. It can be republished for free. For the last two decades, HIV/AIDS has been held at bay by potent antiviral drugs, aggressive testing and inventive public education campaigns. But the COVID-19 pandemic has caused …

Strides Against HIV/AIDS Falter, Especially in the South, as Nation Battles Covid Read More »

Insurance coverage and financing landscape for HIV treatment and prevention in the USA

In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system, examine the major programs that provide coverage and services, and…More

Does Nutritional Yeast Trigger Crohn’s Disease?

Is the exaggerated reaction of many Crohn’s disease patients to baker’s, brewer’s, and nutritional yeast just a consequence of their inflamed leaky gut, or might the yeast be a contributing cause? “Baker’s Yeast in Crohn’s Disease—Can It Kill You?” is the inflammatory title (no pun intended) of a 1999 journal article. Crohn’s disease is an …

Does Nutritional Yeast Trigger Crohn’s Disease? Read More »

New KFF Analysis Finds 40 Out of 46 PEPFAR Countries Have Met At Least One HIV Target, Though No Countries Have Met All Progress Measures

A new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target, 17 countries have met at least half of the targets, and one country has met five targets. No country has met all targets and six have not met any…More

Action needed to preserve the six protected classes

In the final hours of the previous Administration’s time in office, the Center for Medicare & Medicaid Innovation (the Innovation Center) (CMMI) announced new changes for CY 2022 to an existing five-year Part D Payment Modernization Model. This model would provide “formulary flexibility” by exempting Part D plans in the Model from some of Part …

Action needed to preserve the six protected classes Read More »

Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs

Ted Howard started taking Truvada a few years ago because he wanted to protect himself against HIV, the virus that causes AIDS. But the daily pill was so pricey he was seriously thinking about giving it up. Under his insurance plan, the former flight attendant and customer service instructor owed $500 in copayments every month …

Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs Read More »

Potential Health Policy Administrative Actions Under President Biden

This brief outlines the potential health policy actions that President Biden could take using executive authority, based on campaign pledges, and actions that would reverse or modify regulations or guidance issued by the Trump Administration.

Trump’s Anti-Abortion Zeal Shook Fragile Health Systems Around the World

In Ethiopia, health clinics for teenagers once supported by U.S. foreign aid closed down. In Kenya, a decades-long effort to integrate HIV testing and family planning unraveled. And in Nepal, intrepid government workers who once traversed the Himalayas to spread information about reproductive health were halted. Around the world, countries that depend on U.S. foreign …

Trump’s Anti-Abortion Zeal Shook Fragile Health Systems Around the World Read More »

Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments

In comments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare & Medicaid Services (CMS) Medicaid proposed rule. Today, we’re diving deeper into CMS’s proposal to vastly expand the types of medicines that would fall under the definition of a “line extension” and how that …

Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments Read More »

Health Care and the 2020 Presidential Election

This side-by-side comparison examines President Trump’s record and former Vice President Biden’s positions across a wide range of key health issues, including the response to the pandemic, the Affordable Care Act marketplace, Medicaid, Medicare, drug prices, reproductive health, mental health and opioids, immigration and health coverage, and health care costs.

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas

According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of the seven therapeutic areas that IQVIA analyzed, including anticoagulants, asthma/COPD, depression, diabetes, HIV, multiple sclerosis and oncology treatments, average patient cost exposure between 2015 and 2019 …

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas Read More »

Online Event: Highlights from the Virtual AIDS 2020 Conference

Earlier this month, the International AIDS Conference – the world’s largest conference on HIV and AIDS – took place on a virtual stage. Over five days, the conference showcased the latest research and analysis by leaders in the HIV sector. On Friday, July 24, 9:00 a.m. -10:00 a.m., the CSIS Global Health Policy Center and KFF (the Kaiser Family Foundation) will host…More

Insurance Coverage and Viral Suppression Among People with HIV in the United States, 2015-2018

Health insurance coverage and access to care improve health outcomes, including viral suppression, for people with HIV in the United States. Prior research has demonstrated that implementation of the Affordable Care Act (ACA) in 2014 increased coverage among people with HIV and that certain forms of coverage are positively correlated with sustained viral suppression. We …

Insurance Coverage and Viral Suppression Among People with HIV in the United States, 2015-2018 Read More »

Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019

Women and girls represent more than half of all people living with HIV worldwide, and HIV is the leading cause of death among women aged 15-49. This analysis sought to quantify PEPFAR’s role for women and girls in key program areas, analyzing data over time as well as by country, to better understand the extent …

Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019 Read More »

KFF/UNAIDS Analysis Finds Donor Governments Spent US$7.8 Billion for HIV in 2019, Down Almost $200 Million From the Previous Year

Half of the 14 donor governments analyzed in the study decreased their spending on global HIV efforts from 2018 to 2019; six increased; and one held steady. Donor government funding supports HIV care and treatment, prevention and other services in low- and middle-income countries.